Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids

NCT06913790 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2025-04-06

No results posted yet for this study

Summary

This prospective observational cohort study aims to assess changes in central corneal thickness (CCT) in vernal keratoconjunctivitis (VKC) patients using topical steroids. Data will be collected from tertiary care hospitals such as Al-Mustafa eye hospital and Jinnah Hospital, Lahore.

Conditions

  • Vernal Keratoconjunctivitis

Sponsors & Collaborators

  • Superior University

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-20
Primary Completion
2025-06-20
Completion
2026-02-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06913790 on ClinicalTrials.gov